Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial
2007

Hydrocortisone Administration and Blood Sugar Control in Septic Shock

Sample size: 48 publication Evidence: moderate

Author Information

Author(s): Loisa Pekka, Parviainen Ilkka, Tenhunen Jyrki, Hovilehto Seppo, Ruokonen Esko

Primary Institution: Päijät-Häme Central Hospital

Hypothesis

Continuous hydrocortisone infusion would reduce the occurrence of hyperglycemic and hypoglycemic episodes when compared to conventional bolus treatment.

Conclusion

Strict normoglycemia is more easily achieved if the hydrocortisone therapy is given to septic shock patients by continuous infusion.

Supporting Evidence

  • The mean blood glucose levels were similar in both groups.
  • The bolus group had significantly more hyperglycemic episodes than the infusion group.
  • More adjustments in insulin infusion rates were needed in the bolus group.

Takeaway

Giving hydrocortisone continuously helps keep blood sugar levels steady in patients with septic shock, making it easier for doctors to manage their care.

Methodology

This was a prospective randomized study comparing blood glucose profiles and insulin requirements in 48 septic shock patients receiving hydrocortisone by bolus or continuous infusion.

Potential Biases

Potential bias due to lack of blinding and variability in nutritional support.

Limitations

The study was not placebo-controlled or blinded, and nutritional support varied among patients.

Participant Demographics

Patients with septic shock, excluding those under 18, with pre-existing diabetes, or receiving glucocorticoids.

Statistical Information

P-Value

0.039

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/cc5696

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication